Cardiovascular Therapy and Prevention

712

微信好友朋友圈 QQ好友复制链接

查看最新文献

历年发表投稿信息同类期刊

期刊缩写：

CARDIOVASC THER PREV copy

复制

反馈

ISSN：

ISSN是由8个数字组成的编码，旨在识别各种报纸、专业杂志、画报、期刊，无论其性质或载体版本（纸版及电子版）。

print: 1728-8800

研究领域：

Medicine-Cardiology and Cardiovascular Medicine

h-index：

h-index是指该期刊有h篇文章至少被引用h次，是一项简单易懂的评估指标，不像平均值会受极端值影响，可呈现出多数文章的被引用表现。Google使用过去5年的h-index数据评价期刊的影响力，“h5指数”比较难以被人为操控，不会因为多了一篇超高被引论文而明显增长，另一方面，刻意减少发文量也不会对提升h5指数有作用。

Gold OA文章占比：

Gold OA文章占比是指一个总体中金色OA文章数量占总体文章数量的比重。OA期刊的文章主要通过金色通道（Gold road，也称为Gold OA，即期刊官网）和绿色通道（Green road，或Green OA）实现开放获取。金色通道是开放获取期刊通过自己的官网来实现的，而绿色通道是通过把文章自存档于机构知识库(Institutional Repositories，比如哈佛大学学术库DASH）或学科知识库中来实现。

0.00%

原创研究文献占比：

0.00%

SCI收录类型：

Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)

期刊官网：

http://roscardio.ru/en/cardiovascular-therapy-and-prevention.html https://cardiovascular.elpub.ru

期刊介绍英文：

The most important objectives of the journal are: the generalization of scientific and practical achievements in the field of cardiology, increasing scientific and practical skills of cardiologists. The scientific concept of publication does the publication of modern achievements in the field of epidemiology, prevention and treatment of cardiovascular diseases, the results of research, national and international clinical trials. For publication in the journal are invited both domestic and foreign scientists and clinicians working in the field of cardiology, as well as doctors of other specialties. The magazine covers various issues in cardiology and related specialties. Each issue is prepared by Executive editor of the issue, a respected specialist in the field of epidemiology, prevention and treatment of cardiovascular diseases. The main focus of the publication — scientific articles on original research, the pharmacotherapy of cardiovascular disease, new diagnostic methods. All members of the group of authors should meet all four criteria of authorship set forth in the ICMJE recommendations: 1) concept and design development or data analysis and interpretation, and 2) manuscript justification or verification of critical intellectual content, and 3) final approval for publication of the manuscript, and 4) consent to be responsible for all aspects of the work, and assume that issues relating to the thoroughness and diligent execution of any part of the study submitted are duly investigated and resolved. Great importance the editors attached to the preparation of scientific papers by groups of authors at a high level, literacy, authors, and their ownership information, availability of research results not only to colleagues in Russia, but also abroad.

CiteScore：

引用分数（英语：CiteScore，CS）是一种用来反映学术期刊最近发表文章“年平均被引用次数”的衡量指标。该指标由Elsevier于 2016 年 12 月推出，以替代常用的JCR影响因子（由Clarivate计算）。 CiteScore是Scopus中系列期刊指标的一部分，包括 SNIP(源文档标准化影响)，SJR (SClmago杂志排名)，引用文档计数以及引用百分比。

CiteScore	SJR	SNIP	CiteScore排名
1.7	0.212	0.572	学科排名百分位大类：Social Sciences 小类：Education 855 / 1543 44% 大类：Medicine 小类：Cardiology and Cardiovascular Medicine 259 / 387 33%

发文信息

历年发表

年文章数是指每年6月SCI发布的IF数据中所提供的上一年全年发文数量。如2018年7月-2019年6月，显示的是2017年的发文数.对极少数热门期刊，我们会在1月份更新为最新一年的发文数。

2012年	2013年	2014年	2015年	2016年	2017年	2018年	2019年	2020年	2021年	2022年
142	101	135	123	105	106	142	163	197	249	155

投稿信息

出版周期：

Bimonthly

出版语言：

Russian

出版国家(地区)：

Russian Federation

审稿时长：

6-12 weeks

投稿网址：

http://icmje.org/news-and-editorials/sharing_clinical_trial_data_comments_feed.html

出版商：

Vserossiiskoe Obshchestvo Kardiologov

编辑部地址：

SILICEA-POLIGRAF, KASHIRSKOJE SH 24 A/JA 509, MOSCOW, RUSSIA, 115478

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1728-8800%5BISSN%5D

Cardiovascular Therapy and Prevention - 最新文献

查看全部

Biomarkers and subclinical left ventricular dysfunction in patients with type 2 diabetes without clinical manifestations of cardiovascular diseases

Pub Date : 2024-02-25 DOI: 10.15829/1728-8800-2024-3914 T. G. Utina, D. U. Akasheva, D. V. Korsunsky, O. Dzhioeva, O. M. Drapkina

Is meta-analysis the "top of the evidence pyramid" in cardiology?

Pub Date : 2024-02-24 DOI: 10.15829/1728-8800-2024-3925 S. Martsevich

Consensus statement on the management of patients with asymptomatic hyperuricemia in general medical practice

Pub Date : 2024-02-24 DOI: 10.15829/1728-8800-2024-3737 O. M. Drapkina, V. I. Mazurov, A. I. Martynov, E. Nasonov, S. A. Saiganov, A. Lila, R. Bashkinov, I. N. Bobkova, C. Baimukhamedov, I. Z. Gaidukova, N. I. Guseinov, D. Duplyakov, M. Eliseev, A. Mamasaidov, N. A. Martusevich, Khilola T Mirakhmedova, I. Murkamilov, D. Nabieva, V. A. Nevzorova, O. D. Ostroumova, V. Salukhov, G. A. Togizbaev, E. Trofimov, Y. Khalimov, A. Chesnikova, S. Yakushin

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。